Marrow transplantation for severe aplastic anemia with significant renal impairment

@article{Gerrie2007MarrowTF,
  title={Marrow transplantation for severe aplastic anemia with significant renal impairment},
  author={Alina S Gerrie and Judith Marsh and Jeffrey Howard Lipton and H. A. Messner and Vikas Gupta},
  journal={Bone Marrow Transplantation},
  year={2007},
  volume={39},
  pages={311-313}
}
Bone marrow transplantation (BMT) from an HLAmatched sibling donor (MSD) is the treatment of choice in young patients with severe aplastic anemia (SAA) and matched unrelated donor transplant is an option for patients without a MSD after failing immunosuppressive therapy (IST). Anecdotal data in patients with multiple myeloma (MM) and renal insufficiency suggest the feasibility of allografting, the outcomes of BMT in patients with SAA with significant renal impairment are not known. Renal… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 10 references

Chronic kidney disease following nonmyeloablative hematopoietic cell transplantation

T Hamaki, H Katori, +3 authors T Itoh
Am J Transplant • 2006

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation • 2001

in patients with multiple myeloma and renal insufficiency

M Haubitz, F Bohnenstengel, R Brunkhorst, M Schwab, U Hofmann
Bone Marrow Transplant • 1997

Similar Papers

Loading similar papers…